Horizon Space Acquisition Ii CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Horizon Space Acquisition II Corp. has secured a one-month extension to complete its initial business combination by depositing $50,000 into its trust account.
NASDAQ
Horizon Space Acquisition II Corp. announced a $7.8 million PIPE financing to support its business combination with SL Bio Ltd., forming a new public entity, SL Science Holding Limited.
NASDAQ
Horizon Space Acquisition II Corp. extended its deadline to complete a business combination with SL BIO Ltd. to April 18, 2026, funded by a $50,000 unsecured promissory note from William Wang.
NASDAQ
Horizon Space Acquisition II Corp. secured a one-month extension to complete its business combination with SL Bio Ltd. but faces substantial public share redemptions.
NASDAQ
Horizon Space Acquisition II Corp. announced additional independent director nominees and updated beneficial ownership details for its upcoming business combination with SL BIO Ltd.
NASDAQ
Horizon Space Acquisition II Corp. issued a press release clarifying the redemption process for shareholders ahead of its proposed business combination with SL BIO Ltd. and an extension meeting.
NASDAQ
Horizon Space Acquisition II Corp. has postponed its extraordinary general meeting for the proposed business combination with SL Bio Ltd. to February 12, 2026, extending the redemption deadline.
NASDAQ
Horizon Space Acquisition II Corp. filed an 8-K to correct trust and transfer agent details and clarify redemption procedures for its upcoming merger vote with SL BIO Ltd.
NASDAQ
Horizon Space Acquisition II Corp. secured a three-month extension to complete its initial business combination through a $690,000 promissory note.
NASDAQ
Horizon Space Acquisition II Corp. has secured an unsecured promissory note for $300,000 from its sponsor, Horizon Space Acquisition II Sponsor Corp., to fund general working capital ahead of its initial business combination.
NASDAQ
Horizon Space Acquisition II Corp. (HSPT) and SL Bio Ltd. have announced a definitive business combination agreement, setting the stage for SL Science Holding Limited (PubCo) to list on Nasdaq with a valuation of $5.568 billion.
NASDAQ
Horizon Space Acquisition II Corp. announces that its units' ordinary shares and rights can be traded separately starting February 5, 2025.
NASDAQ
Horizon Space Acquisition II Corp. successfully closed its over-allotment option, generating an additional $9 million in gross proceeds and completing a private placement sale of additional units to its sponsor.
NASDAQ
Horizon Space Acquisition II Corp. successfully closed its initial public offering and a private placement, raising a total of $62 million to pursue a business combination.
NASDAQ
Horizon Space Acquisition II Corp. successfully closed its $60 million initial public offering, issuing units comprised of ordinary shares and rights, while also detailing the terms of a rights agreement.